Novocure (Nasdaq: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields (TTFields), visits the Nasdaq MarketSite in Times Square. The company is celebrating its 25th anniversary.
In honor of the occasion, Ashley Cordova, CEO, rings the Opening Bell.